Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
copper (cu-7) (1 trial)
disulfiram (antabuse) (1 trial)
temozolomide (temodar) (1 trial)
Glioblastoma (Phase 2)
Trials (1 total)
Trial APIs (3 total)